Results of the TWENTE trial reported at TCT 2011 Medical Xpress The TWENTE clinical trial, which compared two second generation drug-eluting stents – zotarolimus and everolimus-eluting stents – established non-inferiority between the two stents as measured by the primary endpoint: target vessel failure (TVF) at one ... Results of the TWENTE trial reported at TCT 2011 Results of the EVOLVE trial reported at TCT 2011 |
